Clinical Trial

Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
The study was placed on hold by the Sponsor for \~1 year. Given the prolonged hold and absence of participant activity, the study was closed.
Summary
This study aims to evaluate whether the administration of vaginal estrogen along with Via, a hyaluronic acid-based vaginal moisturizer, offers superior relief from symptoms of genitourinary syndrome of menopause (GSM) in the urogynecologic patient population, compared to administration of vaginal estrogen alone.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-18.
Status change: Not Yet Recruiting → Withdrawn 2026-04-28
Trial Details
NCT Number NCT07038070
Lead Sponsor NYU Langone Health
Conditions Genitourinary Syndrome of Menopause (GSM)
Start Date 2025-07-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-04